Ixabepilone development across the breast cancer continuum: a paradigm shift

od Ibrahim, Nuhad K
Izdano 2010

Ixabepilone: Overview of Effectiveness, Safety, and Tolerability in Metastatic Breast Cancer

od Ibrahim, Nuhad K.
Izdano u Front Oncol (2021)

Prognostic significance of equivocal HER2 results and clinical utility of alternative chromosome 17 genes in patients with invasive breast cancer: a cohort study

od Sneige, Nour, Hess, Kenneth R., Multani, Asha S., Gong, Yun, Ibrahim, Nuhad K.
Izdano u Cancer (2016)

Effect of neoadjuvant chemotherapy regimen on relapse-free survival among patients with breast cancer achieving a pathologic complete response: an early step in the de-escalation o...

od Weiss, Anna, Bashour, Sami I., Hess, Kenneth, Thompson, Alastair M., Ibrahim, Nuhad K.
Izdano u Breast Cancer Res (2018)

Complete Metabolic Response on Interim (18)F‐Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography to Predict Long‐Term Survival in Patients with Breast Cancer Underg...

od Chen, Suyun, Ibrahim, Nuhad K., Yan, Yuanqing, Wong, Stephen T., Wang, Hui, Wong, Franklin C.
Izdano u Oncologist (2017)

Survival Advantage in Patients with Metastatic Breast Cancer Receiving Endocrine Therapy plus Sialyl Tn-KLH Vaccine: Post Hoc Analysis of a Large Randomized Trial

od Ibrahim, Nuhad K., Murray, James L., Zhou, Dapeng, Mittendorf, Elizabeth A., Sample, Dory, Tautchin, Michael, Miles, David
Izdano 2013

Outcomes of changing systemic therapy in patients with relapsed breast cancer and 1 to 3 brain metastases

od Alhalabi, Omar, Soomro, Zaid, Sun, Ryan, Hasanov, Elshad, Albittar, Aya, Tripathy, Debu, Valero, Vicente, Ibrahim, Nuhad K.
Izdano u NPJ Breast Cancer (2021)

Breast Cancer With Brain Metastases: Clinicopathologic Features, Survival, and Paired Biomarker Analysis

od Shen, Qi, Sahin, Aysegul A., Hess, Kenneth R., Suki, Dima, Aldape, Kenneth D., Sawaya, Raymond, Ibrahim, Nuhad K.
Izdano u Oncologist (2015)

BMET-23 ANG1005, A NOVEL BRAIN-PENETRANT PEPTIDE-TAXANE CONJUGATE, FOR THE TREATMENT OF CNS METASTASES FROM BREAST CANCER

od Kumthekar, Priya, Bates, Susan, Kesari, Santosh, Brenner, Andrew, Anders, Carey, Garcia, Agustin, Ibrahim, Nuhad, Tkaczuk, Katherine, Tang, Shou-Ching
Izdano u Neuro Oncol (2015)

Central nervous system miliary metastasis in breast cancer: a case series analysis and proposed identification criteria of a rare metastasis subtype

od Bashour, Sami I., Ibrahim, Nuhad K., Schomer, Donald F., Hess, Kenneth R., Gao, Chao, Tripathy, Debu, Fuller, Gregory N.
Izdano u Br J Cancer (2020)

QOLP-02. PATIENT-REPORTED OUTCOMES FOLLOWING PERTUZUMAB PLUS HIGH-DOSE TRASTUZUMAB IN PATIENTS WITH HER2-POSITIVE METASTATIC BREAST CANCER (MBC) AND CENTRAL NERVOUS SYSTEM (CNS) PR...

od Kumthekar, Priya, Sahebjam, Solmaz, Pegram, Mark, Ibrahim, Nuhad, Sussell, Jesse, Nicholas, Alan, Fung, Anita, Cheng, Anna, Lin, Nancy U
Izdano u Neuro Oncol (2020)

Phase I and II Study of Gemcitabine and Vinorelbine in Heavily Pretreated Patients with Metastatic Breast Cancer and Review of the Literature

od Abdayem, Pamela, Ghosn, Marwan, Valero, Vicente, Walters, Ronald, Arun, Banu, Murray, James L., Theriault, Richard, Frye, Debbie, Ibrahim, Nuhad K.
Izdano 2014

Phase I dose escalation pharmacokinetic assessment of intravenous humanized anti-MUC1 antibody AS1402 in patients with advanced breast cancer

od Pegram, Mark D, Borges, Virginia F, Ibrahim, Nuhad, Fuloria, Jyotsna, Shapiro, Charles, Perez, Susan, Wang, Karen, Schaedli Stark, Franziska, Courtenay Luck, Nigel
Izdano 2009

Results of a phase Ib trial of combination immunotherapy with a CD8+ T cell eliciting vaccine and trastuzumab in breast cancer patients

od Clifton, G. Travis, Litton, Jennifer K., Arrington, Karen, Ponniah, Sathibalan, Ibrahim, Nuhad K., Gall, Victor, Alatrash, Gheath, Peoples, George E., Mittendorf, Elizabeth A.
Izdano u Ann Surg Oncol (2017)

Clinical nomogram to predict bone-only metastasis in patients with early breast carcinoma

od Delpech, Yann, Bashour, Sami I, Lousquy, Ruben, Rouzier, Roman, Hess, Kenneth, Coutant, Charles, Barranger, Emmanuel, Esteva, Francisco J, Ueno, Noato T, Pusztai, Lajos, Ibrahim, Nuhad K
Izdano u Br J Cancer (2015)

Preliminary report of a clinical trial supporting the sequential use of an attenuated E39 peptide (E39') to optimize the immunologic response to the FBP (E39+GM-CSF) vaccine

od Jackson, Doreen, Qiao, Na, Greene, Julia M, Hale, Diane, Berry, John, Trappey, Alfred, Vreeland, Timothy, Clifton, Guy, Ibrahim, Nuhad, Toms, Annie, Peoples, George E, Mittendorf, Elizabeth A
Izdano u J Immunother Cancer (2015)

Phase III Multicenter Clinical Trial of the Sialyl-TN (STn)-Keyhole Limpet Hemocyanin (KLH) Vaccine for Metastatic Breast Cancer

od Miles, David, Roché, Henri, Martin, Miguel, Perren, Timothy J., Cameron, David A., Glaspy, John, Dodwell, David, Parker, Joanne, Mayordomo, José, Tres, Alejandro, Murray, James Lee, Ibrahim, Nuhad K.
Izdano 2011

ATTAIN: Phase III study of etirinotecan pegol versus treatment of physician's choice in patients with metastatic breast cancer and brain metastases

od Tripathy, Debu, Tolaney, Sara M, Seidman, Andrew D, Anders, Carey K, Ibrahim, Nuhad, Rugo, Hope S, Twelves, Chris, Dieras, Veronique, Müller, Volkmar, Tagliaferri, Mary, Hannah, Alison L, Cortés, Javier
Izdano u Future Oncol (2019)

Influencers of the Decision to Undergo Contralateral Prophylactic Mastectomy among Women with Unilateral Breast Cancer

od Singareeka Raghavendra, Akshara, Alameddine, Hala F., Andersen, Clark R., Selber, Jesse C., Brewster, Abenaa M., Barcenas, Carlos H., Caudle, Abigail S., Arun, Banu K., Tripathy, Debu, Ibrahim, Nuhad K.
Izdano u Cancers (Basel) (2021)

Immunologic mapping of glycomes: implications for cancer diagnosis and therapy

od Zhou, Dapeng, Levery, Steven B., Hsu, Fong-Fu, Wang, Peng G., Teneberg, Susann, Almeida, Igor C., Li, Yunsen, Xu, Huaxi, Wang, Lai-Xi, Xia, Chengfeng, Ibrahim, Nuhad K, Michael, Katja
Izdano 2011